2014
DOI: 10.1177/1076029614555902 View full text |Buy / Rent full text
|
|

Abstract: Biosimilar recombinant activated FVII is found to be as effective as Novoseven in the treatment of acute joint bleeding in patients with hemophilia with inhibitors. Its usage will decrease the gaps in hemophilia.

Help me understand this report

Search citation statements

Order By: Relevance
Select...
0
15
0

Publication Types

Select...

Relationship

0
0

Authors

Journals